Section Arrow
ACOG.NASDAQ
- Alpha Cognition Inc
Quotes are at least 15-min delayed:2025/05/28 12:32 EDT
Last
 8.63
-0.19 (-2.15%)
Day High 
9.15 
Prev. Close
8.82 
1-M High
11.4 
Volume 
40.79K 
Bid
8.5
Ask
8.65
Day Low
8.4701 
Open
8.92 
1-M Low
Market Cap 
141.29M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.63 
20-SMA 7.65 
50-SMA 6.01 
52-W High 17.08625 
52-W Low 3.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.28/-1.67
Enterprise Value
141.29M
Balance Sheet
Book Value Per Share
2.55
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.6448+0.4073+171.49%-- 
SPROSpero Therapeutics2.065+1.383+202.79%9.58PE
PLRZPolyrizon Ltd0.9+0.254+39.32%-- 
NCNANuCana plc0.038399-0.000601-1.54%-- 
VERUVeru0.5958+0.0868+17.05%-- 
Quotes are at least 15-min delayed:2025/05/28 12:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.